Fundies.
English

IRONWOOD PHARMACEUTICALS, INC.

EDGAR
IRWD Current report (8-K) · filed 2026-10-16

Annual consolidated revenue for 2025: about Unit_Standard_USD_NgFD7gFrtEijwQdnRTTiqw 296.2M, using the latest reported figures. The previous period, 2024, was about Unit_Standard_USD_NgFD7gFrtEijwQdnRTTiqw 351.4M.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments
Watchlist

Latest quarter

Revenue

113 million Unit_Standard_USD_mrxY2PZs-UWVqz5wXwegOg

2026 Q2 · Unit_Standard_USD_mrxY2PZs-UWVqz5wXwegOg

Exact inputs and evidence
  • Revenue: 113041000 Unit_Standard_USD_mrxY2PZs-UWVqz5wXwegOg Source

Operating margin

70.16%

2026 Q2 · %

Exact inputs and evidence
  • Operating Income: 79307000 Unit_Standard_USD_mrxY2PZs-UWVqz5wXwegOg Source
  • Revenue: 113041000 Unit_Standard_USD_mrxY2PZs-UWVqz5wXwegOg Source
Cash and cash equivalents
79.1 million Unit_Standard_USD_mrxY2PZs-UWVqz5wXwegOg Source
Exact value

79127000 Unit_Standard_USD_mrxY2PZs-UWVqz5wXwegOg

Long-term debt including current maturities
200 million Unit_Standard_USD_BDefYQipIU-iXzxSXDFpqQ Source
Exact value

199506000 Unit_Standard_USD_BDefYQipIU-iXzxSXDFpqQ

Shares outstanding
165 million Unit_Standard_shares_YwVTIVSgr0Oxzka-Rp9Ttg Source
Exact value

165239947 Unit_Standard_shares_YwVTIVSgr0Oxzka-Rp9Ttg

Company performance

Up to ten complete financial years · consolidated figures

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2026-10-16.

Financial data available through: 2025-12-31.

Coverage by financial measure
  • Revenue: 2 of 11 periods available· newest 2025-12-31
  • Operating income: 2 of 11 periods available· newest 2025-12-31
  • Net income: 2 of 11 periods available· newest 2025-12-31
  • Operating cash flow: 2 of 11 periods available· newest 2025-12-31
  • Capital expenditure: 2 of 11 periods available· newest 2025-12-31
  • Total assets: Multiple units; comparison withheld· newest 2025-12-31
  • Total liabilities: 1 of 11 periods available· newest 2025-12-31
  • Current assets: Multiple units; comparison withheld· newest 2025-12-31
  • Current liabilities: Multiple units; comparison withheld· newest 2025-12-31
  • Cash and cash equivalents: Multiple units; comparison withheld· newest 2025-12-31
  • Long-term debt including current maturities: Multiple units; comparison withheld· newest 2024-12-31
  • Shares outstanding: Multiple units; comparison withheld· newest 2025-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

  • Revenue

    -15.7%

    Prior period

    Unit_Standard_USD_NgFD7gFrtEijwQdnRTTiqw 351.41 million

    –

    Current period

    Unit_Standard_USD_NgFD7gFrtEijwQdnRTTiqw 296.15 million

    –

    Exact inputs and evidence

    296151000 − 351410000 = -55259000 Unit_Standard_USD_NgFD7gFrtEijwQdnRTTiqw

    351410000 Unit_Standard_USD_NgFD7gFrtEijwQdnRTTiqw · 2024-01-01 – 2024-12-31

    Inspect prior input Prior source

    296151000 Unit_Standard_USD_NgFD7gFrtEijwQdnRTTiqw · 2025-01-01 – 2025-12-31

    Inspect current input Current source
    Share or cite

    The citation records this snapshot. The page link may show a newer release later.

  • Net income

    +2,629.2%

    Prior period

    Unit_Standard_USD_NgFD7gFrtEijwQdnRTTiqw 880,000

    –

    Current period

    Unit_Standard_USD_NgFD7gFrtEijwQdnRTTiqw 24.02 million

    –

    Exact inputs and evidence

    24017000 − 880000 = 23137000 Unit_Standard_USD_NgFD7gFrtEijwQdnRTTiqw

    880000 Unit_Standard_USD_NgFD7gFrtEijwQdnRTTiqw · 2024-01-01 – 2024-12-31

    Inspect prior input Prior source

    24017000 Unit_Standard_USD_NgFD7gFrtEijwQdnRTTiqw · 2025-01-01 – 2025-12-31

    Inspect current input Current source
    Share or cite

    The citation records this snapshot. The page link may show a newer release later.

  • Operating cash flow

    +22.7%

    Prior period

    Unit_Standard_USD_NgFD7gFrtEijwQdnRTTiqw 103.55 million

    –

    Current period

    Unit_Standard_USD_NgFD7gFrtEijwQdnRTTiqw 127.04 million

    –

    Exact inputs and evidence

    127044000 − 103549000 = 23495000 Unit_Standard_USD_NgFD7gFrtEijwQdnRTTiqw

    103549000 Unit_Standard_USD_NgFD7gFrtEijwQdnRTTiqw · 2024-01-01 – 2024-12-31

    Inspect prior input Prior source

    127044000 Unit_Standard_USD_NgFD7gFrtEijwQdnRTTiqw · 2025-01-01 – 2025-12-31

    Inspect current input Current source
    Share or cite

    The citation records this snapshot. The page link may show a newer release later.

  • Capital expenditure

    -76.1%

    Prior period

    Unit_Standard_USD_NgFD7gFrtEijwQdnRTTiqw 142,000

    –

    Current period

    Unit_Standard_USD_NgFD7gFrtEijwQdnRTTiqw 34,000

    –

    Exact inputs and evidence

    34000 − 142000 = -108000 Unit_Standard_USD_NgFD7gFrtEijwQdnRTTiqw

    142000 Unit_Standard_USD_NgFD7gFrtEijwQdnRTTiqw · 2024-01-01 – 2024-12-31

    Inspect prior input Prior source

    34000 Unit_Standard_USD_NgFD7gFrtEijwQdnRTTiqw · 2025-01-01 – 2025-12-31

    Inspect current input Current source
    Share or cite

    The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2025 2025-01-01 – 2025-12-31

  • Revenue Unit_Standard_USD_NgFD7gFrtEijwQdnRTTiqw 296.15 million 100% of revenue
  • Operating costs Derived Unit_Standard_USD_NgFD7gFrtEijwQdnRTTiqw 197.65 million 67% of revenue
  • Operating income Unit_Standard_USD_NgFD7gFrtEijwQdnRTTiqw 98.5 million 33% of revenue
  • Tax, interest and other Derived Unit_Standard_USD_NgFD7gFrtEijwQdnRTTiqw 74.49 million 25% of revenue
  • Net income Unit_Standard_USD_NgFD7gFrtEijwQdnRTTiqw 24.02 million 8.1% of revenue

Cash

  • Operating cash flow Unit_Standard_USD_NgFD7gFrtEijwQdnRTTiqw 127.04 million 43% of revenue
  • Capital expenditure Unit_Standard_USD_NgFD7gFrtEijwQdnRTTiqw 34,000 0% of revenue
  • Free cash flow Derived Unit_Standard_USD_NgFD7gFrtEijwQdnRTTiqw 127.01 million 43% of revenue

Share of revenue by period

  • Net income
  • Tax, interest and other
  • Operating costs
  • 2024 26%73%
  • 2025 25%67%
Values and sources
Revenue breakdown by annual reporting period
PeriodRevenueOperating costsOperating incomeTax, interest and otherNet incomeFree cash flowSource
2024 2024-01-01 – 2024-12-31351410000 258286000 Derived 93124000 92244000 Derived 880000 103407000 Derived
Source
2025 2025-01-01 – 2025-12-31296151000 197649000 Derived 98502000 74485000 Derived 24017000 127010000 Derived
Source

Amounts are exact, in Unit_Standard_USD_NgFD7gFrtEijwQdnRTTiqw.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

Unit_Standard_USD_NgFD7gFrtEijwQdnRTTiqw 296.2M 2025
Revenue historyRevenue reported for each complete financial period. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.379.5M284.6M189.8M94.9M0.020242025
Values and sources
Revenue values and source evidence
PeriodSeriesValue(Unit_Standard_USD_NgFD7gFrtEijwQdnRTTiqw)Source evidence
2024Revenue351410000
2025Revenue296151000

Revenue growth

Change in revenue from the same financial period one year earlier.

-15.7% 2025
Revenue growth historyChange in revenue from the same financial period one year earlier. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.1.3%-3.3%-7.9%-12.4%-17.0%20242025
Values and sources
Revenue growth values and source evidence
PeriodSeriesValueSource evidence
2024Year over yearNo prior comparable period
2025Year over year-15.7%

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin 33.3% 2025
Net margin 8.1% 2025
Free cash flow margin 42.9% 2025
Profit margins historyOperating income, net income and free cash flow as a share of revenue. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.46%35%23%12%0%20242025
  • Operating margin
  • Net margin
  • Free cash flow margin
Values and sources
Profit margins values and source evidence
PeriodSeriesValueSource evidence
2024Operating margin26.5%
2025Operating margin33.3%
2024Net margin0.3%
2025Net margin8.1%
2024Free cash flow margin29.4%
2025Free cash flow margin42.9%

Operating cash flow

Cash generated by the company’s normal business operations.

Unit_Standard_USD_NgFD7gFrtEijwQdnRTTiqw 127M 2025
Operating cash flow historyCash generated by the company’s normal business operations. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.137.2M102.9M68.6M34.3M0.020242025
Values and sources
Operating cash flow values and source evidence
PeriodSeriesValue(Unit_Standard_USD_NgFD7gFrtEijwQdnRTTiqw)Source evidence
2024Operating cash flow103549000
2025Operating cash flow127044000

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

Unit_Standard_USD_NgFD7gFrtEijwQdnRTTiqw 127M 2025
Free cash flow historyOperating cash flow minus capital expenditure for the same period and unit. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.137.2M102.9M68.6M34.3M0.020242025
Values and sources
Free cash flow values and source evidence
PeriodSeriesValue(Unit_Standard_USD_NgFD7gFrtEijwQdnRTTiqw)Source evidence
2024Free cash flow103407000
2025Free cash flow127010000

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

Not enough comparable data to show this history.
Values and sources
Liabilities to assets values and source evidence
PeriodSeriesValueSource evidence
2024-12-31Liabilities / assetsNot reportedNo source recorded
2025-12-31Liabilities / assetsNot reportedNo source recorded

Current assets to current liabilities

Current assets divided by current liabilities.

Not enough comparable data to show this history.
Values and sources
Current assets to current liabilities values and source evidence
PeriodSeriesValueSource evidence
2024-12-31Current assets / current liabilitiesNot reportedNo source recorded
2025-12-31Current assets / current liabilitiesNot reportedNo source recorded

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
PeriodNet incomeOperating cash flowCapital expenditureFree cash flow
2024 2024-01-01 – 2024-12-31
Unit_Standard_USD_NgFD7gFrtEijwQdnRTTiqw 880,000
Exact value

Exact value: 880000 Unit_Standard_USD_NgFD7gFrtEijwQdnRTTiqw

2024-01-01 – 2024-12-31: 880000 Unit_Standard_USD_NgFD7gFrtEijwQdnRTTiqw Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

Unit_Standard_USD_NgFD7gFrtEijwQdnRTTiqw 103.55 million
Exact value

Exact value: 103549000 Unit_Standard_USD_NgFD7gFrtEijwQdnRTTiqw

2024-01-01 – 2024-12-31: 103549000 Unit_Standard_USD_NgFD7gFrtEijwQdnRTTiqw Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

Unit_Standard_USD_NgFD7gFrtEijwQdnRTTiqw 142,000
Exact value

Exact value: 142000 Unit_Standard_USD_NgFD7gFrtEijwQdnRTTiqw

2024-01-01 – 2024-12-31: 142000 Unit_Standard_USD_NgFD7gFrtEijwQdnRTTiqw Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

Unit_Standard_USD_NgFD7gFrtEijwQdnRTTiqw 103.41 million
Calculation and evidence

103549000 − 142000 Unit_Standard_USD_NgFD7gFrtEijwQdnRTTiqw

Exact free cash flow: 103407000 Unit_Standard_USD_NgFD7gFrtEijwQdnRTTiqw

Share or cite

The citation records this snapshot. The page link may show a newer release later.

2025 2025-01-01 – 2025-12-31
Unit_Standard_USD_NgFD7gFrtEijwQdnRTTiqw 24.02 million
Exact value

Exact value: 24017000 Unit_Standard_USD_NgFD7gFrtEijwQdnRTTiqw

2025-01-01 – 2025-12-31: 24017000 Unit_Standard_USD_NgFD7gFrtEijwQdnRTTiqw Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

Unit_Standard_USD_NgFD7gFrtEijwQdnRTTiqw 127.04 million
Exact value

Exact value: 127044000 Unit_Standard_USD_NgFD7gFrtEijwQdnRTTiqw

2025-01-01 – 2025-12-31: 127044000 Unit_Standard_USD_NgFD7gFrtEijwQdnRTTiqw Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

Unit_Standard_USD_NgFD7gFrtEijwQdnRTTiqw 34,000
Exact value

Exact value: 34000 Unit_Standard_USD_NgFD7gFrtEijwQdnRTTiqw

2025-01-01 – 2025-12-31: 34000 Unit_Standard_USD_NgFD7gFrtEijwQdnRTTiqw Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

Unit_Standard_USD_NgFD7gFrtEijwQdnRTTiqw 127.01 million
Calculation and evidence

127044000 − 34000 Unit_Standard_USD_NgFD7gFrtEijwQdnRTTiqw

Exact free cash flow: 127010000 Unit_Standard_USD_NgFD7gFrtEijwQdnRTTiqw

Share or cite

The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

166 filings · 7,069 latest values · 7,069 originally reported values

Dataset published . Source filing dates and reporting periods are shown separately.

Identifiers: 0001446847, 1446847, IRWD, edgar:1446847

Also known as IRONWOOD PHARMACEUTICALS INC, IRONWOOD PHARMACEUTICALS, INC., IRONWOOD PHARMACEUTICALS, INC.